1. Roswell Park Cancer Institute, Buffalo, NY;
2. Institut de Cancérologie de l’Ouest – site René Gauducheau, Saint Herblain, France;
3. Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada;
4. Vall d’Hebron University, Barcelona, Spain;
5. Azienda Ospedaliera San Gerardo, Monza, Italy;
6. Universitatsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany;
7. Highlands Oncology Group, Fayetteville, AR;
8. Thoraxklinik am Universitätsklinikum Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany;
9. Centre Hospitalier Intercommunal (CHI) Créteil, Créteil, France;
10. Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione Pascale, IRCCS, Napoli, Italy;
11. Medical Oncology Department and Experimental Therapies and Biomarkers in Cancer, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain;
12. AOU San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy;
13. Hospital Universitario Virgen del Rocío, Seville, Spain;
14. European Institute of Oncology (IEO), Milan, Italy;
15. Novartis Pharma AG, Basel, Switzerland;
16. Novartis Healthcare Private Limited, Hyderabad, India;
17. Gustave Roussy Cancer Center, Villejuif, France;